Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
510 participants
OBSERVATIONAL
1992-03-31
2001-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
When a region of the brain is active, it uses more fuel in the form of oxygen and sugar (glucose). As the brain uses more fuel it produces more waste products, carbon dioxide and water. Blood carries fuel to the brain and waste products away from the brain. As brain activity increases, blood flow to and from the area of activity also increases. This is known as regional cerebral blood flow (rCBF). Knowing these facts, researchers can use radioactive water (H215O) and PET scans to observe what areas of the brain are receiving more blood flow.
In this study researchers plan to investigate the changes in regional cerebral blood flow (rCBF) as patients participate in different activities. The activities are designed to stimulate the areas of the brain responsible for voluntary motor activity and sensation. By comparing the results of PET scans performed in different conditions, researchers can locate regions of the brain responsible for specific tasks.
This study should provide new information about voluntary movements in humans and the preparation involved in controlling them.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
NCT02952391
PET Imaging Study of Neurochemical and Autonomic Disorders in Multiple System Atrophy (MSA)
NCT02035761
PET Study of Non-Motor Symptoms of Parkinson Disease
NCT01565473
Non-invasive Brain Mapping of Movement Facilitation in Parkinson's Disease
NCT05179187
Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations
NCT00302146
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institute of Neurological Disorders and Stroke (NINDS)
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Deiber MP, Ibanez V, Honda M, Sadato N, Raman R, Hallett M. Cerebral processes related to visuomotor imagery and generation of simple finger movements studied with positron emission tomography. Neuroimage. 1998 Feb;7(2):73-85. doi: 10.1006/nimg.1997.0314.
Catalan MJ, Honda M, Weeks RA, Cohen LG, Hallett M. The functional neuroanatomy of simple and complex sequential finger movements: a PET study. Brain. 1998 Feb;121 ( Pt 2):253-64. doi: 10.1093/brain/121.2.253.
Deiber MP, Wise SP, Honda M, Catalan MJ, Grafman J, Hallett M. Frontal and parietal networks for conditional motor learning: a positron emission tomography study. J Neurophysiol. 1997 Aug;78(2):977-91. doi: 10.1152/jn.1997.78.2.977.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
92-N-0119
Identifier Type: -
Identifier Source: secondary_id
920119
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.